Bacteriophage therapy of bacterial infections: An update of our institute's experience

Archivum Immunologiae et Therapiae Experimentalis

Volumn 48, Issue 6, 2000, Pages 547-551

  Weber Da̧browska, Beata ^a   Mulczyk, Marian ^a   Górski, Andrzej ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Bacterial infections; Drug resistance; Phage therapy

Indexed keywords

BACTERIAL INFECTION; BACTERIOLYSIS; BACTERIOPHAGE; DRUG RESISTANCE; EPIDEMIOLOGICAL DATA; ESCHERICHIA; HUMAN; IMMUNOCOMPETENCE; IMMUNOREGULATION; KLEBSIELLA; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PLASMID; PSEUDOMONAS; REVIEW; SPECIES DIFFERENTIATION; STAPHYLOCOCCUS;

BACTERIAL INFECTIONS; BACTERIOPHAGES; CYTOKINES; DRUG RESISTANCE, MULTIPLE; HUMANS; POLAND;

EID: 0037824247     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. ACKERMAN H. W. and DUBOW M. (1987): Viruses of prokaryotes. I. General properties of bacteriophages. CRC Press, Boca Roton, Florida.
2. BARROW R. A. and SOOTHILL J. S. (1997): Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential. Trends Microbiol., 5, 258-271.
3. BERCHIERI A. JR., LOVELL M. A. and BARROW P. A. (1991): The activity in the chicken alimentary tract of bacteriophages lytic for Salmonella typhimurium. Res. Microbiol., 142, 541-549.
4. BRUYNOGHE R. and MAISIN J. (1921): Essais de therapeutique au moyem du bactériophage. C. R. Soc. Biol., 85, 1120-1121.
5. CARLTON R. M. (1999): Phage therapy: past history and future prospects. Arch. Immunol. Ther. Exp., 47, 267-274.
6. CISŁO M., DA̧BROWSKI M., WEBER-DA̧BROWSKA B. and WOJTOŃ A. (1987): Bacteriophage treatment of suppurative skin infection. Arch. Immunol. Ther. Exp., 35, 175-183.
7. COHEN M. L. (1992): Epidemiology of drug resistance: implications for a post-antimicrobial era. Science, 257, 1050.
8. GILMORE M. S. and HOCH J. A. (1999): A vancomycine surprise. Nature, 399, 524-527.
9. HOLZMAN D. (1988): Phage as antibacterial tool. Genet. Eng. News, 15 Oct., pp. 1, 12, 41, 48.
10. KUTTER E. (1997): Phage therapy. Bacteriophages as antibiotics. Evergreen State College. Olympia WA 98505 Nov. 15.
11. LORCH A. (1999): Bacteriophages an alternative to antibiotics. Biotech. Develgo Monitor, 39, 14-17.
12. LEDERBERG J. (1996): Commentary. Proc. Acad. Sci. USA, 93, 3167-3168.
13. NEU H. C. (1992): The crisis in antibiotic resistance. Science, 257, 1064-1071.
14. NOVAK R., HENRIQUES B., CHARPENTIER E., NORMARK S. and TUOMANEN E. (1999): Emergence of vancomycin tolerance in Streptococcuspneumoniae. Nature, 399, 590-593.
15. SIERADZKI K., ROBERTS R. B., HABER S. W. and TOMASZ A. (1999): The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus. N. Engl. J. Med., 340, 517-523.
16. SMITH T. L., PEARSON M. L., WILCOX K. R., CRUZ C., LANCASTER M. V., ROBINSON-DUNN B., TENOVER F. C., ZERVOS M. J., BAND J. D., WHITE E. and JARVIS W. R. (1999): Emergence of vancomycin resistance in Staphylococcus aureus. N. Engl. J. Med., 340, 493-501.
17. SMITH H. W. and HUGGINS R. B. (1983): Effectivenes of phages in treating experimental E. coli diarrhoea in calves, piglets and lambs. J. Gen. Microbiol., 129, 2659-2675.
18. SMITH H. W. and HUGGINS R. B. (1987): The control of experimental E. coli in calves by means of bacteriophage. J. Gen. Microbiol., 133, 1111-1126.
19. STRÓJ L., WEBER-DA̧BROWSKA B., PARTYKA K., MULCZYK M. and WÓJCIK M. (1999): Successful bacteriophage treatment in purulent cerebrospinal meningitis in a newborn (in Polish). Neur. Neuroch. Pol., 33, 693-698.
20. ŚLOPEK S., DURLAKOWA I., WEBER-DA̧BROWSKA B., KUCHAREWICZ-KRUKOWSKA A., DA̧BROWSKI M. and BISIKIEWICZ R. (1983): Results of bacteriophage treatment of suppurative bacterial infections. T. General evolution of the results. Arch. Immunol. Ther Exp., 31, 267-291.
21. ŚLOPEK S., DURLAKOWA I., WEBER-DA̧BROWSKA B., KUCHAREWICZ-KRUKOWSKA A., DA̧BROWSKI M. and BISIKIEWICZ R. (1983): Results of bacteriophage treatment of suppurative bacterial infections. II. Detailed evaluation of the results. Arch. Immunol. Ther. Exp., 31, 293-327.
22. ŚLOPEK S., DURLAKOWA I., WEBER-DA̧BROWSKA B. and KUCHAREWICZ-KRUKOWSKA A. (1984): Results of bacteriophage treatment of suppurative bacterial infections. III. Detailed evaluation of the results obtained in further 150 cases. Arch. Immunol. Ther. Exp., 32, 317-335.
23. ŚLOPEK S., KUCHAREWICZ-KRUKOWSKA A., WEBER-DA̧BROWSKA B. and DA̧BROWSKI M. (1985): Results of bacteriophage treatment of suppurative bacterial infections. IV. Evaluation of the results obtained in 370 cases. Arch. Immunol. Ther. Exp., 33, 219-240.
24. ŚLOPEK S., KUCHAREWICZ-KRUKOWSKA A., WEBER-DA̧BROWSKA B. and DA̧BROWSKI M. (1985): Results of bacteriophage treatment of suppurative bacterial infections. V. Evaluation of the results obtained in children. Arch. Immunol. Ther. Exp., 33, 241-260.
25. ŚLOPEK S., KUCHAREWICZ-KRUKOWSKA A., WEBER-DA̧BROWSKA B. and DA̧BROWSKI M. (1985): Results of bacteriophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative Staphylococcus infections. Arch. Immunol. Ther. Exp., 33, 261-273.
26. ŚLOPEK S., WEBER-DA̧BROWSKA B., DA̧BROWSKI M. and KUCHAREWICZ-KRUKOWSKA A. (1987): Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. Arch. Immunol. Ther. Exp., 35, 569-583.
27. VALDVOGEL F. (1999): New resistance in Staphylococcus aureus. N. Engl. J. Med., 340, 556-557.
28. VIEU J. F. (1975): Les Bacteriophages. In FABRE J. (ed.): Fraite de Therapeutique, Vol. Serums et Vaccins. Flammarion, Paris, 337-400.
29. VIEU J. F. et al. (1979): Donnees actueles sur les applications therapeutiques des bacteriophages. Bull. Natl. Med., 103-161.
30. WEBER-DA̧BROWSKA B., KOŹMIŃSKA J., MULCZYK M. and KACZKOWSKI H. (1996): The use of bacteriophages in the treatment of chronic suppurative sinusitis (in Polish). Post. Med. Klin. Dośw., 5, 291-293.
31. WEBER-DA̧BROWSKA B., MULCZYK M. and GÓRSKI A. (2000): Therapy of infections in cancer patients with bacteriophages. Clin. Appl. Immunol. Rev. (in press).
32. WEBER-DA̧BROWSKA B., ZIMECKI M. and MULCZYK M. (2000): Effective phage therapy is associated with normalization of cytokine production by blood cell cultures. Arch. Immunol. Ther. Exp., 48, 31-37.